omniture
3SBIO INC.

Latest News

3SBio Inc. Appoints Dr. Zhenping Zhu as President of Research & Development and Chief Scientific Officer

SHENYANG, China, Jan. 9, 2017 /PRNewswire/ -- 3SBio Inc., (HKEX:1530) ("3SBio" and together with it...

2017-01-09 16:00 2305

3SBio Inc. Selected as a Constituent of the MSCI China Index

SHENYANG, China, May 13, 2016 /PRNewswire/ -- 3SBio Inc., (HKEX:1530) ("3SBio") today announced tha...

2016-05-13 17:00 2551

3SBio's PEG-irinotecan Wins IND Approval From China FDA

SHENYANG, China, March 7, 2016 /PRNewswire/ -- 3SBio Inc., ("3SBio") a leading biotechnology compan...

2016-03-07 17:24 2651

3SBio Inc. Announces Expansion of its Leadership Team

SHENYANG, China, March 4, 2016 /PRNewswire/ -- 3SBio Inc. (Hong Kong: 1530)  ("3SBio" and together ...

2016-03-04 19:03 3423

3SBio Signs Exclusive Patent License Agreement for ALT-P7, an Antibody-drug Conjugate Targeting HER2 with Alteogen

SHENYANG, China, and DAEJEON, Korea, Oct. 12, 2015 /PRNewswire/ -- 3SBio Inc. ("3SBio") (01530.HK),...

2015-10-12 08:05 2206

3SBio Signs Exclusive Patent License Agreement for ALT-P7, an Antibody-drug Conjugate Targeting HER2 with Alteogen

SHENYANG, China, and DAEJEON, Korea, Oct. 11, 2015 /PRNewswire/ -- 3SBio Inc. ("3SBio") (01530.HK), ...

2015-10-12 08:04 1505

3SBio Inc. Selected as a Constituent of the Hang Seng Composite LargeCap & MidCap Index

SHENYANG, China, Aug. 17, 2015 /PRNewswire/ -- 3SBio Inc., (HKEX: 1530) ("3SBio") today announced...

2015-08-17 22:46 1766

3SBio Acquires Zhejiang Wansheng Pharmaceutical

SHENYANG, China, July 24, 2015  /PRNewswire/ -- - Adds integrated small molecule drug R&D and manuf...

2015-07-24 17:07 3000

3SBio Acquires Global Rights to Anti-TNF mAb

SHENYANG, China, June 22, 2015 /PRNewswire/ -- 3SBio Inc., (HKEX: 1530) ("3SBio"), a leadingChina-b...

2015-06-22 20:55 2448

3SBio Acquires Global Rights to Anti-TNF mAb

SHENYANG, China, June 22, 2015 /PRNewswire/ -- 3SBio Inc., (HKEX: 1530) ("3SBio"), a leading China-b...

2015-06-22 20:55 1229

3SBio Acquires Sirton Pharmaceuticals SpA

SHENYANG, China and VILLA GUARDIA, Italy, Jan. 25, 2015 /PRNewswire/-- 3SBio Inc., "3SBio", a leadin...

2015-01-26 11:13 1600

3SBio Signs Exclusive Patent License Agreement for DIG-KT, a Bi-Specific mAb targeting VEGFR2 and Tie-2 with PharmAbcine

SHENYANG, China and DAEJEON, South Korea, Jan. 14, 2015 /PRNewswire/ -- 3SBio Inc. ("3SBio"), a lead...

2015-01-15 08:00 1952

3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine

SHENYANG, China and DAEJEON, Korea, Nov. 18, 2014 /PRNewswire/ -- 3SBio Inc., a leading China-based ...

2014-11-19 08:00 1562

3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China

SHENYANG, China, Sept. 16, 2014 /PRNewswire/ -- 3SBio Inc., ("3SBio") a leading biotechnology compan...

2014-09-17 08:00 1393

3SBio Signs Exclusive Patent License Agreement with DiNonA for Leukotuximab

SHENYANG, China, Aug. 7, 2014 /PRNewswire/ -- 3SBio Inc., a leading China-based biotechnology compan...

2014-08-08 08:00 1982

3SBio Inc. Exclusively Licenses Pegsiticase (Uricase PEG-20) to Selecta Biosciences to Develop Drug Candidate to Treat Gout

SHENYANG, China, June 18, 2014 /PRNewswire/ -- 3SBio Inc., a leading China-based biotechnology compa...

2014-06-18 14:22 1142

3SBio to Develop DJ5 for Progressive Renal Failure in ADPKD Patients

SHENYANG, China, Oct. 29, 2013 /PRNewswire/ -- 3SBio Inc., a leading China-based biotechnology compa...

2013-10-29 18:09 780

3SBio Inc. Announces Completion of Merger

SHENYANG, China, May 30, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), ...

2013-05-30 20:50 842

3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement

SHENYANG, CHINA, May 24, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), ...

2013-05-24 13:51 803

3SBio Inc. Announces Extraordinary General Meeting of Shareholders

SHENYANG, China, May 2, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a...

2013-05-02 13:24 906
12345 ... 7